CDC advisors broaden RSV vaccine recommendations to at-risk adults in their 50s
A CDC advisory panel voted to recommend RSV vaccines for at-risk adults aged 50 to 59, a sought-after expansion by vaccine makers who are trying …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
